Carregant...

COUNTERPOINT: Access to transcatheter aortic valve replacement should not be limited to high-volume surgical centers

Transcatheter aortic valve replacement (TAVR) has transformed the treatment of aortic stenosis in high-risk older adults in Europe and has begun to do so in the United States. Recent Food and Drug Administration approval of the Edwards Lifesciences SAPIEN Transcatheter Heart Valve (Irvine, Calif) in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Green, Philip, Rosner, Gregg F., Leon, Martin B., Schwartz, Allan
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3713505/
https://ncbi.nlm.nih.gov/pubmed/23679964
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtcvs.2013.02.079
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!